Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with recurrent epithelial ovarian carcinoma (EOC) after complete response (CR) to 1st-line platinum (Pt)-based ct: Primary analysis of a phase 2, open-label, randomized, multicenter trial.
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-06-01 / J Clin Oncol 36, 2018 (suppl; abstr e17515)Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-04-11 / Sci Transl Med 2018 Apr;10(436)MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2017-10-20 / Biochem. Biophys. Res. Commun. 2017 12;494(1-2):13-19Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase
/in International Publications, Newcastle Disease Virus, Ovarian Cancer /von 2017-07-27 / J. Virol. 2017 08;91(16)Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2017-06-06 / Clin Transl Oncol 2017 Dec;19(12):1489-1497Cancer Vaccines in Ovarian Cancer: How Can We Improve?
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2016-05-03 / Biomedicines 2016 May;4(2)A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2015-05-29 / J Clin Oncol 33, 2015 (suppl; abstr e14033)Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2015-02-26 / Gynecol. Oncol. 2015 May;137(2):335-42[The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer – 229 clinical cases]
/in Endometrial Cancer, International Publications, Ovarian Cancer /von 2014-10-01 / Gan To Kagaku Ryoho 2014 Oct;41(10):1295-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de